Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference Cannabis Investing News
Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for THOR-707 Biotech Investing
Lexaria Bioscience and Hill Street Beverage Co. Enter Global Manufacturing & Licensing Partnership Cannabis Investing News
Cytokinetics Granted European Orphan Designation for Reldesemtiv to Treat Spinal Musclar Atrophy Biotech Investing
Diffusion Pharmaceuticals Reports Safety Data for Phase 3 INTACT Study in Glioblastoma Patients Biotech Investing
La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118 Pharmaceutical Investing
Naturally Splendid Strengthens Marketing Programs in Advance of Edible Markets Cannabis Investing News
